期刊文献+

细胞毒T细胞 被引量:1

Cytotoxic T Cell
下载PDF
导出
摘要 细胞毒T细胞(CTL)分为CD8+CTLs、CD4+CTLs和CD4-CD8-CTLs几个亚群,它来源于淋巴样造血干细胞的T细胞库,在胸腺中发育成熟,并在周围淋巴组织中活化。效应CTL对靶细胞实行杀伤的途径主要有两条:FasL-Fas介导的细胞凋亡作用和颗粒胞吐途径介导的溶细胞作用。由于CTL在抗肿瘤和抗病毒中效应显著,因而受到广泛重视。 Department of Immunology,Institute of Basic Medical Sciences,CAMS and PUMC,Beijing100005 Cytotoxic T cell(CTL)covers several subtypes,which are CD8 + ,CD4and CD4 - CD8 - .CTL derives from T cell repertoire in lymphoid hematopoietic stem cells.It matures in thymus and is activated in peripheral lymphoid tissues.Effector CTL kills the target cells by2ways.One is apoptotic effect mediated by FasL-Fas pathway and the other one is cytolytic effect mediated by granzymes.CTL has aroused great attention due to its significance in anti-tumor and anti-virus.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2002年第4期439-442,共4页 Acta Academiae Medicinae Sinicae
关键词 细胞毒T细胞 FAS/FASL 颗粒酶 穿孔素 细胞凋亡 cytotoxic T cell FasL-Fas granzyme perforin
  • 相关文献

参考文献9

  • 1[1]Wodarz D, May RM, Nowak MA. The role of antigenindependent persistence of memory cytotoxic T lymphocytes.Inter Immunol, 1999, 12:467-477 被引量:1
  • 2[2]bennett SR, Carbone FR, Karamalis F, et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling.Nature, 1998, 393:478-480 被引量:1
  • 3[3]Schoenberger SP, Tose RE, van der Voort El. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature, 1998, 393:480-483 被引量:1
  • 4[4]Jager E, Jager D, Knuth A. CTL-defined cancer vaccines:perspectives for active immunotherapeutic interventions in minimal residual disease. Cancer Metastasis Rev, 1999, 18:143-150 被引量:1
  • 5[5]Price DA, Kleneman P, Boath BL, et al. Cytotoxic T lymphocytes, chemokines and antiviral immunity. Immunol Today,1999, 20:212-216 被引量:1
  • 6[6]Edwards KM, Davis JE, Browne KA, et al. Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction.Immunnol Cell Bio, 1999, 77:76-89 被引量:1
  • 7[7]Schmittel A, Keilholz U, Thiel E, et al. Quantification of tumor-specific T lymphocytes with the ELISPOT assay. J Immunother, 2000, 23:289-295 被引量:1
  • 8[8]Smyth M J, Godfray DL, Trapan JA. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol, 2001,2:293-299 被引量:1
  • 9[9]Radoja S, Frey AB. Cancer-induced defective cytotoxic T lymphocyte effector function: another mechanism how antigenic tumors escape immune-mediated killing. Mol Med, 2000,6:465-479 被引量:1

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部